Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A Phase II Study of Panobinostat in Paediatric& Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma& Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma
Protocol ID
ACCT008 (NORTH)
Disease (Sub Disease)
Brain and Spinal Tumours (ATRT)
Solid tumours (Neuroblastoma)
Solid tumours (Osteosarcoma)
Solid tumours (Neuroblastoma)
Solid tumours (Osteosarcoma)
Diagnosis Stage
New diagnosis
Relapse/refractory
Relapse/refractory
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 40 years of age
ANZCTR
ACTRN12618000321246
| Study Title | A Phase II Study of Panobinostat in Paediatric& Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma& Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma |
|---|---|
| Protocol ID | ACCT008 (NORTH) |
| Disease (Sub Disease) | Brain and Spinal Tumours (ATRT) Solid tumours (Neuroblastoma) Solid tumours (Osteosarcoma) |
| Diagnosis Stage | New diagnosis Relapse/refractory |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group |
| Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374371&isReview=true |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 17/08/2018 |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | up to 40 years of age |
| ANZCTR | ACTRN12618000321246 |